help show this help message and exit --config.file CONFIG_FILE Path to config file (/etc/prometheus/pve.yml) --web.listen-address WEB_LISTEN_ADDRESS Address on which to expose metrics and web server. ...

If you want whiter teeth, you don't need to shell out huge amounts on professional services. DIY teeth whitening products can get you a brighter smile at home. We've found the best comprehensive ...

Teeth-whitening treatments are relatively new to my own routine, and I’ve noticed that with consistent use, they help me keep that just-left-the-dentist-clean look (especially a month or two ...

In week 4, it was Teeth's turn to reveal herself - and the identity of the celebrity underneath truly shocked the judges, who had previously guessed the likes of Fearne Cotton, Emily Atack ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we see new data on a next-generation obesity candidate from ...

AbbVie has partnered with Neomorph to develop new molecular glue degraders (MGDs) for multiple targets across oncology and immunology, with the deal worth $1.64bn. The collaboration and ...

AbbVie has completed the acquisition of Nimble Therapeutics. Credit: © AbbVie Inc. All rights reserved. AbbVie and Neomorph are forming a partnership and option-to ...

Today, a brief rundown of news involving Merck & Co. and AstraZeneca, as well as updates from AbbVie, Stealth BioTherapeutics and Vigil Neuroscience that you may have missed. Aardvark Therapeutics ...

NORTH CHICAGO, Ill. - AbbVie (NYSE: NYSE:ABBV), a prominent player in the biotechnology industry with a market capitalization of $299 billion, and Neomorph, Inc. have entered into a collaboration to ...

"At Neomorph, we have spent years building a unique molecular glue platform with broad coverage of the proteome," said Phil Chamberlain, DPhil, Co-Founder, President, and Chief Executive Officer ...

The North Chicago-based company announced today it entered into an option-to-license agreement with San Diego-based Neomorph to develop novel therapies for cancers and immune diseases. Neomorph ...